Entac Medical
Entac Medical is a digital health company specializing in wearable device technology. They develop devices that analyze biological acoustic signals using predictive analytics and AI to anticipate patient adverse events, specifically focusing on gastrointestinal impairment (GII) and postoperative ileus (POI). Their core product, PrevisEA™, is a noninvasive device placed on a patient's abdomen post-surgery to monitor digestive health. It provides a 'High Risk' or 'Low Risk' assessment via the Previs™ Index, indicating suitability for early oral refeeding and potential discharge. The Previs™ CDP is a complementary program designed to improve clinical documentation and coding accuracy for POI. The company aims to optimize patient outcomes, reduce hospital readmissions, and lower healthcare costs through proactive risk mitigation.
Entac Medical
Entac Medical is a digital health company specializing in wearable device technology. They develop devices that analyze biological acoustic signals using predictive analytics and AI to anticipate patient adverse events, specifically focusing on gastrointestinal impairment (GII) and postoperative ileus (POI). Their core product, PrevisEA™, is a noninvasive device placed on a patient's abdomen post-surgery to monitor digestive health. It provides a 'High Risk' or 'Low Risk' assessment via the Previs™ Index, indicating suitability for early oral refeeding and potential discharge. The Previs™ CDP is a complementary program designed to improve clinical documentation and coding accuracy for POI. The company aims to optimize patient outcomes, reduce hospital readmissions, and lower healthcare costs through proactive risk mitigation.
TL;DR
Product: PrevisEA — wearable abdominal device that predicts postoperative ileus (POI) using audio spectral analysis
Founded / HQ: Founded 2011; Germantown / Memphis, Tennessee, USA
Founders / Leadership: Buddy Lyons (Founder & CEO) and John Cromwell (Founder & Chief Medical Officer)
Employees: Approximately 8
Funding: Multiple rounds with a reported Series B on 2020-02-11; total funding reported USD 3,270,000
Company Overview
Problem Domain
Predictive/diagnostic medical devices for gastrointestinal impairment and postoperative ileus
Founded
2011
Industry
Medical devices; Digital health
Tech Stack
Funding Track Record
Company profile lists four funding rounds with a Series B announced on this date
Investor Signal
“Innova Memphis; iSelect Fund; Angel Syndicates Central; Sage Fund”